相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Relevance of necroptosis in cancer
Najoua Lalaoui et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes
B. Heinrich et al.
ONCOTARGETS AND THERAPY (2017)
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Zuqiang Liu et al.
NATURE COMMUNICATIONS (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Programmed cell death as a defence against infection
Ine Jorgensen et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment
Laetitia Fend et al.
ONCOIMMUNOLOGY (2016)
First oncolytic virus approved for melanoma immunotherapy
Jonathan Pol et al.
ONCOIMMUNOLOGY (2016)
HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients (Publication with Expression of Concern. See vol. 26, pg. 1529, 2020)
Andrea Napolitano et al.
CLINICAL CANCER RESEARCH (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Christina Pfirschke et al.
IMMUNITY (2016)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
The epigenetic landscape of T cell exhaustion
Debattama R. Sen et al.
SCIENCE (2016)
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Tania Love Aaes et al.
CELL REPORTS (2016)
Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death-1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition
Patricia Kleinpeter et al.
ONCOIMMUNOLOGY (2016)
Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy
Marcin P. Komorowski et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines
Spencer D. Martin et al.
PLOS ONE (2016)
The oncolytic peptide LTX-315 triggers necrotic cell death
Sabrina Forveille et al.
CELL CYCLE (2015)
The role of oncolytic virus immunotherapies to subvert cancer immune evasion
Samuel T. Workenhe et al.
FUTURE ONCOLOGY (2015)
Clonal Deletion Prunes but Does Not Eliminate Self-Specific αβ CD8+ T Lymphocytes
Wong Yu et al.
IMMUNITY (2015)
Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity
Khalil Karimi et al.
INNATE IMMUNITY (2015)
Theoretical study of the dimerization of aqueous beryllium cations
Xiaoyan Jin et al.
JOURNAL OF MOLECULAR MODELING (2015)
Necroptosis and its role in inflammation
Manolis Pasparakis et al.
NATURE (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer
Jialing Zhang et al.
CELL AND BIOSCIENCE (2015)
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D. Garg et al.
FRONTIERS IN IMMUNOLOGY (2015)
Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
Ilkka Liikanen et al.
ONCOIMMUNOLOGY (2015)
The ever-expanding immunomodulatory role of calreticulin in cancer immunity
Marco de Bruyn et al.
FRONTIERS IN ONCOLOGY (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)
Caroline J. Breitbach et al.
ONCOLYTIC VIROTHERAPY (2015)
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Contribution of humoral immune responses to the antitumor effects mediated by anthracyclines
D. Hannani et al.
CELL DEATH AND DIFFERENTIATION (2014)
Molecular mechanisms of ATP secretion during immunogenic cell death
I. Martins et al.
CELL DEATH AND DIFFERENTIATION (2014)
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8
A. Q. Sukkurwala et al.
CELL DEATH AND DIFFERENTIATION (2014)
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Yong-Chen Lu et al.
CLINICAL CANCER RESEARCH (2014)
High hydrostatic pressure induces immunogenic cell death in human tumor cells
Jitka Fucikova et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Chemotherapeutic Drugs Induce ATP Release via Caspase-gated Pannexin-1 Channels and a Caspase/Pannexin-1-independent Mechanism
Andrea Boyd-Tressler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection
David L. Veyer et al.
JOURNAL OF GENERAL VIROLOGY (2014)
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
Banzhou Pan et al.
MOLECULAR CANCER (2014)
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
Christine E. Engeland et al.
MOLECULAR THERAPY (2014)
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
Hong Jiang et al.
PLOS ONE (2014)
ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses
Abhishek D. Garg et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2014)
JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
Ben Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp et al.
ONCOIMMUNOLOGY (2014)
Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity
Zong Sheng Guo et al.
FRONTIERS IN ONCOLOGY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy
Yi Luo et al.
EUROPEAN JOURNAL OF CANCER (2013)
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Yuting Ma et al.
IMMUNITY (2013)
Cytokine patterns in patients with cancer: a systematic review
Bodo E. Lippitz
LANCET ONCOLOGY (2013)
Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
Ilkka Liikanen et al.
MOLECULAR THERAPY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy
Samuel T. Workenhe et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Rewiring cancer cell death to enhance oncolytic viro-immunotherapy
Samuel T. Workenhe et al.
ONCOIMMUNOLOGY (2013)
Rules of Engagement: Molecular Insights from Host-Virus Arms Races
Matthew D. Daugherty et al.
ANNUAL REVIEW OF GENETICS, VOL 46 (2012)
HMGB1 Promotes Drug Resistance in Osteosarcoma
Jun Huang et al.
CANCER RESEARCH (2012)
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Sandro Jube et al.
CANCER RESEARCH (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system
Metamia Ciampricotti et al.
NATURE MEDICINE (2012)
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
Laurie Menger et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The three main stumbling blocks for anticancer T cells
Lukas Baitsch et al.
TRENDS IN IMMUNOLOGY (2012)
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
Mickael Michaud et al.
ONCOIMMUNOLOGY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
Sebastian F. M. Haeusler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
Giovanna Schiavoni et al.
CANCER RESEARCH (2011)
IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells
Jeanette E. Boudreau et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Sergey Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2011)
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
Sylvain Ladoire et al.
JOURNAL OF PATHOLOGY (2011)
Human Adenovirus Type 5 Induces Cell Lysis through Autophagy and Autophagy-Triggered Caspase Activity
Hong Jiang et al.
JOURNAL OF VIROLOGY (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
Antonella Sistigu et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
Dachuan Jin et al.
CANCER RESEARCH (2010)
Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
Roberta Zappasodi et al.
CANCER RESEARCH (2010)
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Laurence Zitvogel et al.
CLINICAL CANCER RESEARCH (2010)
Viral strategies for the evasion of immunogenic cell death
L. Galluzzi et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W. Bridle et al.
MOLECULAR THERAPY (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
Mark P. Chao et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
Alessandra Soriani et al.
BLOOD (2009)
NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses
Philippe Krebs et al.
BLOOD (2009)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
Hye Won Chung et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Complete but curtailed T-cell response to very low-affinity antigen
Dietmar Zehn et al.
NATURE (2009)
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
T. Panaretakis et al.
CELL DEATH AND DIFFERENTIATION (2008)
Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model
Maria A. Thomas et al.
MOLECULAR THERAPY (2008)
A(2A) receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
Paul E. Zarek et al.
BLOOD (2008)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands
Leslie Elsner et al.
JOURNAL OF IMMUNOLOGY (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity
Anthony T. Power et al.
MOLECULAR THERAPY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2
Man Yu et al.
SHOCK (2006)
The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2
ZS Guo et al.
CANCER RESEARCH (2005)
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte
SJ Gardai et al.
CELL (2005)
NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor
M Vitale et al.
BLOOD (2005)
DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction
C Adam et al.
BLOOD (2005)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin
B Berwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
High mobility group box protein 1: An endogenous signal for dendritic cell maturation and Th1 polarization
D Messmer et al.
JOURNAL OF IMMUNOLOGY (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells
B Berwin et al.
EMBO JOURNAL (2003)
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
T Bonaldi et al.
EMBO JOURNAL (2003)
Natural killer cells activated by MHC class Ilow targets prime dendritic cells to induce protective CD8 T cell responses
R Mocikat et al.
IMMUNITY (2003)
Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94
C Gross et al.
BIOLOGICAL CHEMISTRY (2003)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway
S Basu et al.
INTERNATIONAL IMMUNOLOGY (2000)
分享论文
